Colorcon Launches New Titanium Dioxide Free Moisture Protection Coating for Pharmaceutical Tablets

Colorcon, a company that participates in the development and supply of film coating systems, specialty excipients, and functional packaging for healthcare industries, announced on Sept. 5, 2023 the launch of a new Opadry film coating system to address the moisture management needs for pharmaceutical tablets without the use of titanium dioxide (TiO2), according to the press release.

“With uncertainty around the future of TiO2 use in pharmaceutical products marketed in the European Union, global pharmaceutical manufacturers are now formulating their products without the inclusion of TiO2,” said Annabel Bordmann, Film Coatings General Manager, in a press release. “Many pharmaceutical active ingredients are moisture sensitive and require a protective coating. This new Opadry formulation delivers the TiO2 free claim and provides functional moisture protection while upholding productivity levels and overall cost effectiveness.”

Colorcon provides customers with Opadry complete film coating systems, which intends to help reduce complexity with delivering high-quality products and ingredients.

“Moisture management is a critical aspect of pharmaceutical formulations and manufacturing, especially when it comes to tablets. Exposure of active pharmaceutical ingredients (APIs) in tablets to the environmental moisture, reduces product stability,” said Dr Ali Rajabi-Siahboomi, VP & Chief Innovation Officer, in a press release. “With Colorcon’s in-depth knowledge of materials, coating technology and regulatory needs, we have developed this new Opadry TiO2 free formulation that is specifically designed to deliver protection from environmental moisture on storage and during use by patients. The coating is easy to apply and efficient for manufacturers”.

Source: Colorcon